Skip to content

Novo Holdings

VC fundPublic sources — Collected from public sources, not yet cross-checked.

Novo Holdings is a vc fund. It joined 2 rounds tracked by OSH in the last 90 days.

What they look for

Activity

2
Deals, 90 days
2
Deals, 12 months
2
Led, 12 months
$192M
Median disclosed round

Frequent co-investors:SV Health InvestorsJefferson Life SciencesSynconaOxford Science EnterprisesNorthpond Ventures

Computed from OSH Rounds. A deal is a round the investor led or joined.

Portfolio from OSH Rounds

  • Oct 16 · Series C

    OMass Therapeutics€275M

    Led by Bain Capital Life Sciences, Forbion, Novo Holdings · with Janus Henderson Investors, +9

    1 source

  • Oct 1 · Series A

    Breye Therapeutics€67.5M

    Led by Mission BioCapital, Novo Holdings · with Sound Bioventures, +6

    1 source

Questions and answers

How active is Novo Holdings?

In OSH Rounds, Novo Holdings joined 2 rounds in the last 90 days and 2 in the last 12 months, leading 2.

Something wrong? Suggest a correction.

Sources

  1. 1.Denmark’s Breye Therapeutics raises €67.5 million to advance oral therapies for early treatment of retinal diseases — EU-Startups, Oct 2, 2026
  2. 2.Oxford spin-out OMass Therapeutics lands €275 million to bring novel small-molecule therapies closer to patients — EU-Startups, Oct 16, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 16, 2026